{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:34:29Z","timestamp":1773282869401,"version":"3.50.1"},"reference-count":12,"publisher":"S. Karger AG","issue":"3","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Int"],"published-print":{"date-parts":[[2016]]},"abstract":"<b><i>Introduction:<\/i><\/b> Prostatic artery embolization (PAE) has recently started to be viewed as a promising technology that could be an alternative to different treatment options of benign prostatic hyperplasia (BPH), especially in high-risk patients. The aim of our study was to evaluate the efficacy and safety of PAE in BPH patients who are at high risk for surgery and\/or anesthesia. <b><i>Materials and Methods:<\/i><\/b> Between June 2013 and February 2015, BPH patients >50 years with lower urinary tract symptoms (LUTS) refractory to BPH-related medical therapy or had an indwelling urethral catheter due to refractory urine retention were prospectively enrolled in the study. All patients were at high risk for surgery and\/or anesthesia. The PAE was performed and the embolising material used was biosphere 300-500 \u00b5m particles. Pre- and 1, 3, 9 months post-intervention, all patients were assessed by detailed medical history, physical examination, serum prostate-specific antigen (PSA), uroflowmetry, and abdominal and transrectal ultrasonography. <b><i>Results:<\/i><\/b> Twenty-two consecutive patients with a mean age of 72.50 years and a mean prostate volume of 77.30 \u00b1 14.89 cm<sup>3<\/sup> were included. The PAE procedure was successful in all patients. Throughout the period of follow-up, there was a significant improvement in the LUTS and urinary flow rate, and reduction in prostate volume and serum PSA (for all p < 0.001). No major complications were reported. <b><i>Conclusion:<\/i><\/b> Our results show that BPH patients with failed medical treatment who are at high risk for surgery and\/or anesthesia could be treated safely and effectively through PAE.<\/jats:p>","DOI":"10.1159\/000447360","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T03:28:17Z","timestamp":1466652497000},"page":"320-324","source":"Crossref","is-referenced-by-count":14,"title":["Prostatic Artery Embolization: A Promising Technique in the Treatment of High-Risk Patients with Benign Prostatic Hyperplasia"],"prefix":"10.1159","volume":"97","author":[{"given":"Ahmed H.","family":"Gabr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed F.","family":"Gabr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basheer N.","family":"Elmohamady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abul-fotouh","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2016,6,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12810"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-014-0447-3"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-009-9727-z"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pros.10339"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2010.09.030"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-0443(07)61638-8"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2463070647"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2008.11.014"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2012.12.019"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410x.1999.00908.x"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.euus.2004.02.001"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13073-5"}],"container-title":["Urologia Internationalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/447360","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/447360","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/447360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:52:07Z","timestamp":1745427127000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000447360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,10,11]]},"published-print":{"date-parts":[[2016,10,13]]}},"URL":"https:\/\/doi.org\/10.1159\/000447360","archive":["Portico"],"relation":{},"ISSN":["0042-1138","1423-0399"],"issn-type":[{"value":"0042-1138","type":"print"},{"value":"1423-0399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}